Search Results
Mar 04, 2026, 13:44 ET BrainXell Launches Human iPSC-Derived Sensory Neurons for Translational Neuroscience and Pain Biology Research
Nav1.7, Nav1.8, and Nav1.9, TRP channels TRPV1 and TRPM8, the purinergic receptor P2RX3, and lineage-associated markers PRPH, ISL1, and POU4F1. Opioid receptor expression, including OPRM1, OPRK1, and OPRL1, further supports pharmacological applications relevant to analgesic
More news about: BrainXell, Inc
Aug 14, 2025, 12:30 ET Biotech Stocks Rally as Oncology Market Targets $866B by 2034
promising biotech from a potential breakthrough like Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), ProPhase Labs, Inc. (NASDAQ: PRPH), IO Biotech, Inc. (NASDAQ: IOBT), Olema Pharmaceuticals, Inc. (NASDAQ: OLMA), and PDS Biotechnology Corporation (NASDAQ: PDSB).
More news about: Equity Insider
Jun 18, 2025, 11:19 ET Cancer Rates Are Surging in Young Adults -- Here's Where the Smart Money Is Going
(NASDAQ: ONCY) (TSX: ONC), Galectin Therapeutics, Inc. (NASDAQ: GALT), ProPhase Labs, Inc. (NASDAQ: PRPH), CG Oncology, Inc. (NASDAQ: CGON), and Perspective Therapeutics, Inc. (NYSE-American: CATX).
More news about: USA News Group